The Lancet Respiratory Medicine: December 05, 2013 ~ The Lancet Respiratory Medicine in conversation with Podcast

Klaus Rabe discusses a study that looks at ADRB2 polymorphisms
and drug efficacy in preventing COPD exacerbations in patients
from the POET trial.

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

The Lancet Respiratory Medicine: December 05, 2013

Beschreibung

Weitere Episoden

Joan Soriano on Global Epidemiology of Respiratory Disease

Lorenzo Guglielmetti parla del trial clinico ENDTB-Q (in Italian)

Carole Mitnick & Lorenzo Guglielmetti on the ENDTB-Q trial

Laura Garriga-Grimau on bronchiectasis in children and young people

Marcus J Schultz and Prashant Nasa on defining and subphenotyping ARDS

Kommentare (0)

Abonnenten

Anmelden mit